Minerva Neurosciences, Inc(NASDAQ:NERV) 
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, a compound in Phase III clinical trial for the treatment o...
Website: http://www.minervaneurosciences.com
Founded: 2007
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.51
H 1.51
L 1.26
C 1.37
V 52,081
10EMA 1.37
20EMA 1.37
60EMA 1.37
120EMA 1.37
250EMA 1.37